Oppedahl Patent Law Firm LLC will be offering a webinar on "Biotech/pharma subject-matter -- Patentability at the EPO and how to avoid pitfalls for US based applicants" on July 17, 2018 from 7:30 to 9:30 am (Mountain Time). Sandra Pohlman of df-mp (Munich, Germany) and Klaus-Peter Döpfer, Director Biotechnology, EPO will look at the patentability of biotech/pharma subject‑matter under the European Patent Convention (EPC) and discuss exceptions to patentability. The webinar will enable participants to draft claims that comply with the EPC encompassing subject-matter such as plants/animals, (stem) cells, micro‑organisms, methods of surgery and diagnosis, antibodies and nucleic acids and medical uses thereof, personalised medicine and dose regimens. The webinar will also deal with PCT applications as the basis for European applications, including possible pitfalls.
While there is no cost to participate in the program, advance registration is required. Those interested in attending the webinar can register here.
Comments